Risk factors and clinical outcomes of encapsulating peritoneal sclerosis: A case–control study from China

Author:

Lu Miaoqing12,Ye Hongjian12,Chen Dongni12,Yi Chunyan12,Lin Jianxiong12,Mao Haiping12,Yang Xiao12ORCID,Yu Xueqing12ORCID,Chen Wei12ORCID

Affiliation:

1. Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

2. Key Laboratory of Nephrology, National Health Commission and Guangdong Province, Guangzhou, China

Abstract

Background: Encapsulating peritoneal sclerosis (EPS) is an uncommon, but serious complication in patients with continuous ambulatory peritoneal dialysis (PD) who have a considerable mortality rate. This study aimed to identify risk factors and outcomes of EPS in Chinese patients on PD. Methods: Sixteen patients on PD who met the International Society for Peritoneal Dialysis criteria for diagnosis of EPS in the First Affiliated Hospital of Sun Yat-Sen University from 1997 to 2018 were included. Patients without EPS were matched for age, sex and the duration of PD and selected at a 1:3 ratio for the controls. A case–control study was conducted to analyse the clinical profile and risk factors associated with EPS in patients. Results: The prevalence of EPS in patients on PD in our centre was 0.55%. The percentage of EPS significantly increased with the duration of PD. In univariate regression analysis, a history of peritonitis (odds ratios (OR): 2.83; 95% confidence interval (CI): 0.82–9.68; p = 0.08), peritoneal glucose exposure (OR: 1.12; 95% CI: 1.03–1.22; p < 0.01) and a high peritoneal transport status (OR: 14.70; 95% CI: 1.85–117.02; p < 0.01) were associated with EPS in patients on PD. However in the multivariate model, only a high peritoneal transport status (adjusted odds ratios (aOR): 13.65; 95% CI: 1.69–109.96; p = 0.01) was independently associated with EPS. Conclusion: The rate of EPS significantly increases with the duration of PD. Progressive peritoneal dysfunction, especially a high peritoneal transport status, is associated with a higher risk of EPS in this population.

Funder

Chinese National Key Technology R and D Program, Ministry of Science and Technology

Publisher

SAGE Publications

Subject

Nephrology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3